Genesys International Corp Intrinsic Value
GENESYS Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹138.72 | ₹110.98 - ₹166.46 | -67.8% | EPS: ₹11.56, Sector P/E: 12x |
| Book Value Method | asset | ₹278.50 | ₹250.65 - ₹306.35 | -35.3% | Book Value/Share: ₹278.50, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹129.60 | ₹116.64 - ₹142.56 | -69.9% | Revenue/Share: ₹162.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹403.23 | ₹362.91 - ₹443.55 | -6.3% | EBITDA: ₹136.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹172.14 | ₹137.71 - ₹206.57 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹129.10 | ₹116.19 - ₹142.01 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹129.10 | ₹116.19 - ₹142.01 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹240.00 | ₹216.00 - ₹264.00 | -44.2% | ROE: 8.6%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹269.14 | ₹242.23 - ₹296.05 | -37.5% | EPS: ₹11.56, BVPS: ₹278.50 |
Want to compare with current market value? Check GENESYS share price latest .
Valuation Comparison Chart
GENESYS Intrinsic Value Analysis
What is the intrinsic value of GENESYS?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Genesys International Corp (GENESYS) is ₹172.14 (median value). With the current market price of ₹430.35, this represents a -60.0% variance from our estimated fair value.
The valuation range spans from ₹129.10 to ₹403.23, indicating ₹129.10 - ₹403.23.
Is GENESYS undervalued or overvalued?
Based on our multi-method analysis, Genesys International Corp (GENESYS) appears to be trading above calculated value by approximately 60.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 14.22 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.40 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 8.6% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 39.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.42x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Genesys International Corp
Additional stock information and data for GENESYS
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-53 Cr | ₹-62 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹19 Cr | ₹-21 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹-35 Cr | ₹-130 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹28 Cr | ₹18 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹19 Cr | ₹13 Cr | Positive Free Cash Flow | 8/10 |